Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
July 2020
in “Journal of Cosmetic Dermatology”
TLDR Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
The article suggests that genetic variations in the androgen receptor may be a contributing factor to the racial disparities in COVID-19 deaths. The authors propose that androgens may be implicated in COVID-19 disease severity and that special attention may need to be given to African Americans infected with the virus. The article suggests that anti-androgens or androgen modulating drugs may be beneficial in treating COVID-19, particularly if androgen sensitivity can be confirmed as a predisposition to SARS-Cov-2 disease severity.
View this study on onlinelibrary.wiley.com →
Cited in this study
research What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.
research A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
Male pattern hair loss could hint at androgens affecting COVID-19 severity.